The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC).
 
Aseem Anand
Consulting or Advisory Role - EXINI Diagnostics
 
Michael J. Morris
Consulting or Advisory Role - Astellas Pharma; Bayer; Millennium; Progenics
Research Funding - Agensys (Inst); Bayer (Inst); Janssen Oncology (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - fujifilm
 
Steven M. Larson
Consulting or Advisory Role - Cynvec; Prescient Therapeutics; Samus
 
Mattias Ohlsson
Stock and Other Ownership Interests - EXINI Diagnostics
 
Andreas Joseffson
No Relationships to Disclose
 
John Thomas Helgstrand
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Sanofi
 
Lars Edenbrandt
Employment - EXINI Diagnostics
Stock and Other Ownership Interests - EXINI Diagnostics
 
Peter Sander Oturai
No Relationships to Disclose
 
M. Andreas Roeder
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Anders Bjartell
Honoraria - Astellas Pharma; EXINI Diagnostics
Consulting or Advisory Role - Astellas Pharma; EXINI Diagnostics
Travel, Accommodations, Expenses - Astellas Pharma; EXINI Diagnostics